CMS Open Payments · Program Year 2024
Greiner Bio-One North America, Inc.
Greiner Bio-One North America, Inc. reported $11,564.97 across General Payments, Research, and Ownership to 33 physicians and teaching hospitals across 33 transactions.
- $11.6K
- All-tracks total
- 33
- Transactions
- 33
- Recipients
- #1622
- of 1,925 companies
Greiner Bio-One North America, Inc. reported $11,564.97 across all CMS Open Payments tracks (General + Research + Ownership) to 33 physicians and teaching hospitals in Program Year 2024 - ranking #1622 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $11,564.97, averaging $350.45 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer greiner-bio-one-north-america-inc Greiner Bio-One North America, Inc.
$11.6K · #1622/1,925 · 0.0% industry · PY2024
- TOT $11.6K
- RANK #1622
- SHARE 0.0%
- TXN 33
- RCP 33
- CAT 4
- GEN $11.6K
- TOP1 21.7%
- PY 2024
Volume peers
Nearest volume peer: Biobeat USA Inc. ($11.6K)
Greiner Bio-One North America, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Greiner Bio-One North America, Inc.
Greiner Bio-One North America, Inc. ranks #1622 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $11,564.97 across 33 transactions to 33 physicians and teaching hospitals - $350.45 per transaction and $350.45 per recipient on average.
"Travel and Lodging" leads the 4-category general-payment breakdown below at $6.5K (55.9% of General Payments, 15 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Travel and Lodging" leads Greiner Bio-One North America, Inc.'s 4-category general-payment breakdown at $6.5K, 55.9% of the reported total.
Greiner Bio-One North America, Inc. reports 4 general-payment categories - the top three are Travel and Lodging (55.9%), Food and Beverage (39.0%), and Entertainment (3.0%). The remaining 1 category make up 2.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Greiner Bio-One North America, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Travel and Lodging | $6.5K | 15 | 55.9% |
| Food and Beverage | $4.5K | 6 | 39.0% |
| Entertainment | $349.50 | 5 | 3.0% |
| Gift | $235.20 | 7 | 2.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $10,455.93 (90.4%) of $11,564.97 in this company's General Payments records across 6 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Greiner Bio-One North America, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Uh Cleveland Medical Center
$2,507.67 across 7 reported transactions
- 2
Ut Md Anderson Cancer Center
$2,111.14 across 5 reported transactions
- 3
Riverside Methodist Hospital
$2,053.36 across 6 reported transactions
- 4
Childrens Hospital
$1,916.28 across 5 reported transactions
- 5
Geisinger Medical Center
$1,867.48 across 6 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Greiner Bio-One North America, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Greiner Bio-One North America, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Greiner Bio-One North America, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
EnableCV Inc.
Biolase MG LLC
Xenco Medical LLC
Hoya Surgical Optics, Inc
Maxx Health Inc
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.